Business context and reporting period
Nanobiotix S.A. filed this Form 6-K as a foreign private issuer for October 2026. It reports that the company issued a press release on October 1, 2026, and incorporates that release as Exhibit 99.1. The press release itself is not included in the provided filing text.
Financial and operating information
The provided text contains no revenue, profit, cash flow, margin, debt, liquidity, or other operating metrics.
Changes, outlook, and risks
No material changes versus a prior period, guidance, management commentary, risks, contingencies, or unusual items are described in the provided text.
Important facts to verify
- Review Exhibit 99.1, the October 1, 2026 press release, for the underlying announcement and any financial or operating details.
- Confirm whether the press release contains material forward-looking statements, risks, or other disclosures.